Eloxx Pharmaceuticals Inc - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Eloxx Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary

The Eloxx Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Eloxx Pharmaceuticals Inc since January2007.

Synopsis

The Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Eloxx Pharmaceuticals Incs contact information and business Summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Eloxx Pharmaceuticals Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Eloxx Pharmaceuticals Incs M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Eloxx Pharmaceuticals Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Eloxx Pharmaceuticals Incs financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Eloxx Pharmaceuticals Incs growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors business structure and growth strategies.

COMPANY OVERVIEW AND KEY FACTS 2
5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions - Overview 8
Mergers and Acquisitions - Deal reports 9
CORPORATE VENTURING 15
Corporate Venturing - Overview 15
Corporate Venturing - Deal reports 16
PARTNERSHIP 22
Partnership - Deal reports 22
CAPITAL RAISING 52
Capital Raising - Overview 52
Capital Raising - Deal reports 53
PRIVATE EQUITY & OWNERSHIP 83
Private Equity and Ownership - Deal reports 83
APPENDIX 88
Contact Us 88
About MarketLine Financial Deals Database 88
Deal Definition and Methodology 90
About MarketLine 97

List Of Tables


Table 1: Sevion Therapeutics Inc M&A volume and value trend (2014-YTD2018)
Table 2: Sevion Therapeutics Inc M&A activity by geography (2014-YTD2018)
Table 3: Sevion Therapeutics Inc corporate venturing volume and value trend (2014-YTD2018)
Table 4: Sevion Therapeutics Inc corporate venturing by geography (2014-YTD2018)
Table 5: Sevion Therapeutics Inc capital raising volume and value trend (2014-YTD2018)
Table 6: Sevion Therapeutics Inc capital raising by deal type (2014-YTD2018)

List Of Figures


Figure 1: Sevion Therapeutics Inc M&A volume and value trend (2014-YTD2018)
Figure 2: Sevion Therapeutics Inc M&A activity by geography (2014-YTD2018)
Figure 3: Sevion Therapeutics Inc corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Sevion Therapeutics Inc corporate venturing by geography (2014-YTD2018)
Figure 5: Sevion Therapeutics Inc capital raising volume and value trend (2014-YTD2018)
Figure 6: Sevion Therapeutics Inc capital raising by deal type (2014-YTD2018)

Eloxx Pharmaceuticals Inc (ELOX) - Financial and Strategic SWOT Analysis Review

Eloxx Pharmaceuticals Inc (ELOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Eloxx Pharmaceuticals Inc - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Eloxx Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Eloxx Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350 View Report

EyePoint Pharmaceuticals Inc (PSDV) - Product Pipeline Analysis, 2019 Update

EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available